Latest
Welcome to Pregnancy Tests Wholesale.
Point-of-care testing allows patient diagnoses in the physician’s office, an ambulance, the home, the field, or in the hospital. The results of care are timely, and allow rapid treatment to the patient. Empowering clinicians to make decisions at the “point-of-care” has the potential to significantly impact health care delivery and to address the challenges of health disparities. The success of a potential shift from curative medicine, to predictive, personalized, and preemptive medicine could rely on the development of portable diagnostic and monitoring devices for point-of-care testing.
Point-Of-Care Yesterday
• In the earliest days of medicine, health care was similar to point-of-care in that it was delivered in the patient’s home through physician house visits.
• As medical discoveries were made and new technologies developed, care then shifted to specialized hospitals with an emphasis on curative medicine.
• Large centralized laboratories were established, with cost-savings realized through the development of automated systems for analysis of patient samples.
• Point-of-care devices were used on a limited basis in the hospital for rapid analysis in intensive care units and for simple home testing, such as with pregnancy test kits.
• Point-of-care testing gives immediate results as samples do not have to be shipped off-site to a centralized laboratory.
• The NIH supports the development of sensor and micro-system technologies for point-of-care testing. These instruments combine multiple analytical functions into self-contained, portable devices that can be used by non-specialists to detect and diagnose disease, and can enable the selection of optimal therapies through patient screening and monitoring of a patient’s response to a chosen treatment.
• Sensor technologies enable the rapid analysis of blood samples for several critical care assays, including blood chemistry, electrolytes, blood gases, and hematology.
• Biosensors are used clinically for toxicology and drug screens, measurement of blood cells and blood coagulations, bedside diagnosis of heart disease through detection of cardiac markers in the blood, and glucose self-testing.
• Urinary tract infections are a serious health problem affecting millions of people each year. They result in more than 8 million office visits and over a million hospitalizations each year. The total cost for treatment reaches into the billions of dollars. A large share of that expense comes from waiting 48 hours for a urine sample to be cultured in the lab. The quick detection allows the patient to leave the physician’s office or clinic with a prescription specific for their infection to begin immediate treatment.
Point-Of-Care Tomorrow
• With the development of miniaturized devices and wireless communication, the way in which doctors care for patients will change dramatically and the role patients take in their own health care will increase. Health care will become more personalized through tailoring of interventions to individual patients.
• The next decade will bring a new realm of precision and efficiency to the way information is transmitted and interpreted and thus the way medicine is practiced. In the future, clinicians may be able to improve the regulation of diet in infants with inborn errors of metabolism through bedside monitoring. Currently, management of such diseases requires complex testing in a hospital setting. However, researchers are developing a chemical sensor, using a small sample of blood from a finger stick, that changes color in response to metabolic irregularities. When such abnormalities are found, the diet of the infant can be adjusted immediately to prevent adverse effects such as mental retardation.
• Low-cost diagnostic imaging devices can be used at the point-of-patient care for disadvantaged and under-served populations in the U.S. as well as in the developing world. The development of low-cost imaging devices could make affordable diagnostic imaging more widely available, particularly in remote or rural communities and small hospitals that do not have ready access to these technologies.
• A new, low-cost ultrasound device could be used to diagnose complication of pregnancy, hemorrhage associated with trauma, renal obstructions, and other conditions.
• A new method using an optical probe for cervical cancer detection and treatment could significantly lower
the mortality rate worldwide. Combining a small optical imaging device with a treatment modality could provide both
diagnosis and treatment of cervical cancer at the same time.
Thank you for visiting our website. Please fill out the following form to request information about our products and services or to provide feedback about our site. When you are finished, click the 'Submit' button to send us your message.
Point-of-care testing allows patient diagnoses in the physician’s office, an ambulance, the home, the field, or in the hospital. The results of care are timely, and allow rapid treatment to the patient. Empowering clinicians to make decisions at the “point-of-care” has the potential to significantly impact health care delivery and to address the challenges of health disparities. The success of a potential shift from curative medicine, to predictive, personalized, and preemptive medicine could rely on the development of portable diagnostic and monitoring devices for point-of-care testing.
Point-Of-Care Yesterday
• In the earliest days of medicine, health care was similar to point-of-care in that it was delivered in the patient’s home through physician house visits.
• As medical discoveries were made and new technologies developed, care then shifted to specialized hospitals with an emphasis on curative medicine.
• Large centralized laboratories were established, with cost-savings realized through the development of automated systems for analysis of patient samples.
• Point-of-care devices were used on a limited basis in the hospital for rapid analysis in intensive care units and for simple home testing, such as with pregnancy test kits.
Point-Of-Care Today
Reimbursements
Commonly used CPT codes (non-DOA) as of September 2009:
| Product | Avg.Reimb. | CPT Code |
| hCG Pregnancy Urine Test Strip, Cassette, or Midstream | $8.84 | 81025 |
| hCG Pregnancy Urine/Serum Test Strip or Cassette | $10.49 | 84703 |
| LH Ovulation Urine Test Strip, Cassette, or Midstream | $14.02 | 84830 |
| FSH Menopause Urine Test Strip, Cassette, or Midstream | $25.97 | 83001 |
| H. Pylori Serum Test Strip or Cassette | $18.09 | 86318 |
| H. Pylori Whole Blood/Serum Test Strip or Cassette | $18.09 | 86318 |
| Strep A Test Strip or Device | $16.76 | 87880 |
PLEASE NOTE: The above listed CPT Codes and Average Reimbursements are provided as suggestions and estimates only and are subject to change and should not be considered guaranteed. For the most current information on state by state fee schedules visit www.cms.hhs.gov
• Point-of-care testing gives immediate results as samples do not have to be shipped off-site to a centralized laboratory.
• The NIH supports the development of sensor and microsystem technologies for point-of-care testing. These instruments combine multiple analytical functions into self-contained, portable devices that can be used by non-specialists to detect and diagnose disease, and can enable the selection of optimal therapies through patient screening and monitoring of a patient’s response to a chosen treatment.
v Sensor technologies enable the rapid analysis of blood samples for several critical care assays, including blood chemistry, electrolytes, blood gases, and hematology.
• Biosensors are used clinically for toxicology and drug screens, measurement of blood cells and blood coagulations, bedside diagnosis of heart disease through detection of cardiac markers in the blood, and glucose self-testing.
• Urinary tract infections are a serious health problem affecting millions of people each year. They result in more than 8 million office visits and over a million hospitalizations each year. The total cost for treatment reaches into the billions of dollars. A large share of that expense comes from waiting 48 hours for a urine sample to be cultured in the lab. The quick detection allows the patient to leave the physician’s office or clinic with a prescription specific for their infection to begin immediate treatment.
Point-Of-Care Tomorrow
• With the development of miniaturized devices and wireless communication, the way in which doctors care for patients will change dramatically and the role patients take in their own health care will increase. Health care will become more personalized through tailoring of interventions to individual patients.
• The next decade will bring a new realm of precision and efficiency to the way information is transmitted and interpreted and thus the way medicine is practiced. In the future, clinicans may be able to improve the regulation of diet in infants with inborn errors of metabolism through bedside monitoring. Currently, management of such diseases requires complex testing in a hospital setting. However, researchers are developing a chemical sensor, using a small sample of blood from a fingerstick, that changes color in response to metabolic irregularities. When such abnormalities are found, the diet of the infant can be adjusted immediately to prevent adverse effects such as mental retardation.
• Low-cost diagnostic imaging devices can be used at the point-of-patient care for disadvantaged and under-served populations in the U.S. as well as in the developing world. The development of low-cost imaging devices could make affordable diagnostic imaging more widely available, particularly in remote or rural communities and small hospitals that do not have ready access to these technologies.
• A new, low-cost ultrasound device could be used to diagnose complication of pregnancy, hemorrhage associated with trauma, renal obstructions, and other conditions.
• A new method using an optical probe for cervical cancer detection and treatment could significantly lower the mortality rate worldwide. Combining a small optical imaging device with a treatment modality could provide both diagnosis and treatment of cervical cancer at the same time.
Thank you for visiting.